DXS INTERNATIONAL PLC

(AQSE: DXSP)

Result of DXS AGM 2024

The Board of DXS International plc ("the Company” or "DXSP”), the AQSE Growth Market quoted healthcare information and digital clinical decision support systems provider, is pleased to announce that all resolutions put to shareholders at the Company's annual general meeting ("AGM") held yesterday were duly passed.

All resolutions were passed on a poll and the votes received from shareholders on each resolution put to the AGM are set out below.

Get the latest news
delivered to your inbox
Sign up for The Manila Times newsletters
By signing up with an email address, I acknowledge that I have read and agree to the Terms of Service and Privacy Policy.

ResolutionVotes for *%Votes

against

%Votes withheld **
      
Resolution 113,664,949100.00%00.00%0
Resolution 213,664,949100.00%00.00%0
Resolution 313,657,05999.94%5,0000.04%2,890
Resolution 413,659,94999.96%5,0000.04%0
Resolution 513,609,94999.60%55,0000.40%0
Resolution 613,659,94999.96%5,0000.04%0
*  Includes discretionary votes

**        A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" any of the resolutions

During the AGM, the Company's CEO, David Immelman, provided an update on DXS's progress. The Presentation is available for download from the Company's website at https://www.dxs-systems.co.uk/corporate-documents.php No new information was provided in this presentation.

The Directors of DXS International plc accept responsibility for this announcement.

Contacts:

David Immelman

DXS International plc

www.dxs-systems.com

01252 719800
AQSE Corporate Broker and Corporate Advisor

Hybridan LLP

Claire Louise Noyce

020 3764 2341

Notes to Editors

About DXS:

DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively and which should significantly contribute towards the NHS achieving its projected efficiency savings.